Get started
Author

Irantzu Serrano-Mendioroz

Observed names: I Serrano-Mendioroz, Irantzu Serrano, Irantzu serrano
Observed institutions: Universidad Pública de Navarra (UPNA), Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Centro de Investigación Médica Aplicada, Universidad de Navarra
ORCID: 0000-0001-5860-1130
Observed ORCID: 0000-0001-5860-1130
OpenAlex ID: A5087850806
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
2025 · Giulia Petroni, Claudia Galassi, et al. · Nature Cancer · 34
Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency
2016 · María Collantes, Irantzu Serrano-Mendioroz, et al. · Human Molecular Genetics · 29
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
2023 · Maria E Rodriguez-Ruiz, Irantzu Serrano-Mendioroz, et al. · Journal for ImmunoTherapy of Cancer · 26
PDF
An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria
2017 · Irantzu Serrano-Mendioroz, Ana Sampedro, et al. · Human Gene Therapy · 20
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
2025 · Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, et al. · Journal for ImmunoTherapy of Cancer · 18
PDF
Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria
2018 · Irantzu Serrano-Mendioroz, Ana Sampedro, et al. · Human Molecular Genetics · 18
PDF
Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria
2022 · Karol M. Córdoba, Irantzu Serrano-Mendioroz, et al. · Science Translational Medicine · 16
PDF
Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression
2015 · C Unzu, I Melero, et al. · Gene Therapy · 16
A simple method to assess clonogenic survival of irradiated cancer cells
2023 · Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, et al. · Methods in cell biology · 13
Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus
2014 · Carmen Unzu, Ignacio Melero, et al. · PLoS ONE · 9
PDF
Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells
2011 · Mirja Rotinen, Joaquín Villar, et al. · Molecular and Cellular Endocrinology · 9
Assessment of hypoxia by pimonidazole staining following radiotherapy
2022 · Sara Labiano, Irantzu Serrano-Mendioroz, et al. · Methods in cell biology · 8
Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria
2015 · Irantzu Serrano-Mendioroz, Ana Sampedro, et al. · Journal of Proteomics · 4
Fruquintinib saddles tumor immune tolerance by curbing pro-tumoral immature myeloid cell populations
2025 · Lucía Suárez, María Martínez-Azcona, et al. · Frontiers in Immunology · 2
PDF
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
2025 · Giulia Petroni, Claudia Galassi, et al. · Nature Cancer · 2
PDF
Radiotherapy protocols for mouse cancer model
2024 · Eneko Garate-Soraluze, Javier Marco-Sanz, et al. · Methods in cell biology · 2
Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model
2018 · Diego Vera-Yunca, Irantzu Serrano-Mendioroz, et al. · Molecular Genetics and Metabolism · 2
Methods to assess radiation induced abscopal responses in mice
2023 · Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, et al. · Methods in cell biology · 1
Flow cytometry-assisted quantification of immune cells infiltrating irradiated tumors in mice
2022 · Sara Labiano, Irantzu Serrano-Mendioroz, et al. · Methods in cell biology · 1
1115 Cross-priming by type-1 conventional dendritic cells is critically involved in the efficacy of radiotherapy against cancer
2026 · Maria Rodriguez-Ruiz, Leticia Fernandez-Rubio, et al. · Journal for ImmunoTherapy of Cancer
PDF
781 4–1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
2024 · Eneko Garate, Irantzu Serrano-Mendioroz, et al. · Journal for ImmunoTherapy of Cancer
Abstract 1100: 4-1BBL agonist targeted to fibroblast activation protein α synergizes with radiotherapy in murine breast tumor
2023 · Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, et al. · Cancer Research
1144 IL17-producing γδ T cells promote resistance to CDK4/6 inhibitors in HR+HER2- breast cancer
2022 · Giulia Petroni, Kenneth Gouin, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 6216: Intratumoral B0112 in combination with radiotherapy synergizes to achieve CD8 T cell mediated local tumor control
2022 · Maria.E. Rodriguez-Ruiz, Irantzu serrano, et al. · Cancer Research
Works count: 24
Citation count: 230
H-index: 9
I10-index: 9
Year
Topic
Type